Increased levels of corticotropin-releasing hormone or corticosterone/cortisol with FGF21 or FGF21 analog treatment have been reported in rodents, but not in non-human primates nor in any human studies (183, 293, 313)
When you are putting something into your body, especially through injection, the source matters enormously
Botulinum neurotoxin (BoNT) proteases 19,20 are in widespread clinical use and could be promising starting points for such a strategy in light of their catalytic mechanism, modular architecture 21 , intrinsic ability to self-deliver into target cells 22 and demonstrated evolvability 23,24,25
That opened a clearer pathway for 503A compounding pharmacies to fill prescriptions from licensed clinicians
Accessed May 2023 at
Harms, N., Ras, J., Reijnders, W